Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11464775 Pyruvate kinase modulators and use thereof

Patent 11464775 was granted and assigned to Agios Pharmaceuticals on October, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Agios Pharmaceuticals

Current Assignee

Agios Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

114647750

Patent Inventor Names

Jingjing Ji0

Zhihua Sui0

Zhenwei Cai0

Anil Kumar Padyana0

Charles Kung0

Dawei Cui0

Giovanni Cianchetta0

Tao Liu0

Date of Patent

October 11, 2022

Patent Application Number

166390860

Date Filed

August 15, 2018

Patent Citations

‌

US Patent 11040036 Pyruvate kinase activators for use in treating blood disorders

Patent Citations Received

‌

US Patent 12133853 Pyruvate kinase activators for use in treating blood disorders

‌

US Patent 11872225 Pyruvate kinase modulators and use thereof

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11464775 Pyruvate kinase modulators and use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API